Increased Expression of Heat Shock Protein 27 Correlates With Peritoneal Metastasis in Epithelial Ovarian Cancer

Abstract

Ovarian cancer is the third most common gynecologic malignancy and the leading cause of death in gynecological cancer. Although the 5-year survival rate is increasing, peritoneal metastasis of ovarian cancer is still a problem because of no potential predictor. Heat shock proteins (HSPs) are a class of functionally related proteins that are highly expressed in many malignant cancers. Previous studies suggest high levels of HSP27 present in the serum of patients with ovarian cancer. In this study, we investigated whether the expression of HSP27 in epithelial ovarian cancer tissue was associated with peritoneal metastasis and whether HSP27 could be used as a potential predictor of peritoneal metastasis in epithelial ovarian cancer. Tissues from epithelial ovarian cancer with or without peritoneal metastasis were collected and the levels of HSP27 messenger RNA and protein determined by real-time polymerase chain reaction and Western blotting. Immunohistochemistry was used to determine the subcellular localization of HSP27. Immunohistochemistry images showed that HSP27 was highly expressed in the cytoplasm of epithelial cancer cells with peritoneal metastasis. Messenger RNA and protein levels of HSP27 were significantly increased in epithelial ovarian cancer with peritoneal metastasis compared with epithelial ovarian cancer without peritoneal metastasis. Higher expression of HSP27 correlated with poor clinical outcome. These data suggest that higher level of HSP27 was associated with peritoneal metastasis in epithelial ovarian cancer. Heat shock protein 27 may be a useful prognostic marker of poor survival and may provide a basis for the development of molecular therapeutics modulating this survival pathway.

Keywords

epithelial ovarian cancer HSP27 peritoneal metastasis

Get full access to this article

View all access options for this article.

References

Edwards

Brown

Wingo

. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Nat Cancer Inst. 2005;97(17):1407.

McGuire

Hoskins

Brady

. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 1996;334(1):1–6.

Chow

Chen

. Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology. Eur J Gynaecol Oncol. 2010;31(1):55–62.

Cohen

Dromard

Petignat

. Heat shock proteins in ovarian cancer: a potential target for therapy. Gynecol oncol. 2010;119(1):164–166.

De Maio

. Heat shock proteins: facts, thoughts, and dreams. Shock. 1999;11(1):1.

Mattila

Valtonen

Nieminen

Asikainen

. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin infect dis. 1998;26(3):719.

Tang

Khaleque

Jones

. Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones. 2005;10(1):46.

Elpek

GÖ

Karaveli

Kele

Aksoy

. Expression of heat shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries. APMIS. 2003;111(4):523–530.

Arts

HJG

Hollema

Lemstra

. Heat shock protein 27 (HSP27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis. Int J cancer. 1999;84(3):234–238.

10.

Sarto

Binz

Mocarelli

. Heat shock proteins in human cancer. Electrophoresis. 2000;21(6):1218–1226.

11.

Olejek

Damasiewicz-Bodzek

Bodzek

. Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma. Int J Gynecol Cancer. 2009;19(9):1516.

12.

Rui

Jian Guo

Yuan Peng

Hai

Bing Gen

. Use of serological proteomic methods to find biomarkers associated with breast cancer. Proteomics. 2003;3(4):433–439.

13.

Vargas-Roig

Fanelli

Lopez

. Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev. 1997;21(5):441.

14.

Alaiya

Franzén

Moberger

Silfverswärd

Linder

Auer

. Two dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity. Electrophoresis. 1999;20(4-5):1039–1046.

15.

Jiang

Ying

. Identification of metastasis associated proteins by proteomic analysis and functional exploration of interleukin 18 in metastasis. Proteomics. 2003;3(5):724–737.

16.

Kim

Lee

. Proteome analysis of human liver tumor tissue by two dimensional gel electrophoresis and matrixassisted laser desorption/ionization mass spectrometry for identification of disease related proteins. Electrophoresis. 2002;23(24):4142–4156.

17.

Adams

Hajj

Edwards

Bjercke

McGuire

. Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies. Cancer res. 1983;43(9):4297.

18.

Tenniswood

Guenette

Lakins

Mooibroek

Wong

Welsh

. Active cell death in hormone-dependent tissues. Cancer Metastasis Rev. 1992;11(2):197–220.

19.

Love

King

. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br J cancer. 1994;69(4):743.

20.

Foster

Dodson

Ambroisine

. Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J cancer. 2009;101(7):1137–1144.

21.

Morino

Tsuzuki

Ishikawa

. Specific regulation of HSPs in human tumor cell lines by flavonoids. In Vivo. 1997;11(3):265.

22.

Lemieux

Oesterreich

Lawrence

. The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis. 1997;17(3):113.

23.

Oesterreich

Weng

Qiu

Hilsenbeck

Osborne

Fuqua

SAW

. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res. 1993;53(19):4443.

24.

Annunziata

Kleinberg

Davidson

. BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer. Clin Cancer Res. 2007;13(22):6585.

25.

Ciocca

Calderwood

. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005;10(2):86.

26.

Melle

Ernst

Escher

. Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clin chem. 2007;53(4):629.

27.

Beere

. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Investigation. 2005;115(10):2633.

28.

Elstrand

Kleinberg

Kohn

Trope

Davidson

. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Int J Gynecol Pathol. 2009;28(3):211–221.

29.

Fujiwara

Shirafuji

Fushitani

Fujimoto

Kohno

Modest

. Change in the localization of heat shock protein 27 (HSP 27) in BG-1 human ovarian cancer cells following treatment by the ether lipid ET-18-OCH3. Anticancer Res. 1999;19(1A):181–187.

30.

Marin

Tanguay

. Stage-specific localization of the small heat shock protein Hsp27 during oogenesis inDrosophila melanogaster. Chromosoma. 1996;105(3):142–149.

31.

Robitaille

Simard-Bisson

Larouche

Tanguay

Blouin

Germain

. The small heat-shock protein Hsp27 undergoes ERK-dependent phosphorylation and redistribution to the cytoskeleton in response to dual leucine zipper-bearing kinase expression. J Invest Dermatol. 2009;130(1):74–85.

32.

Jiang

Woronicz

Liu

Goeddel

. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science. 1999;283(5401):543.

33.

Miki

Eddy

. Tumor necrosis factor receptor 1 is an ATPase regulated by silencer of death domain. Mol Cell Biol. 2002;22(8):2536.